Hunan Jingfeng Pharmaceutical Co.,Ltd. Posted 648,956 Yuan Net Loss in First Three Quarters of 2022

Hunan Jingfeng Pharmaceutical Co.,Ltd. (湖南景峰医药股份有限公司) (000908.SZ) reported a net loss of 648,956 yuan in the first three quarters of 2022, reversing a net profit of 19.1 million yuan for the same period in the previous year.

Meanwhile, the company posted 611.8 million yuan in revenue, up 9.3% year-on-year.

At the end of the reporting period, it had 1.6 billion yuan in total assets and 1.3 billion yuan in total liabilities, with a liability-to-asset ratio of 79.9%.